Advertisement

Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg 600x60px
Document › Details

Marinomed Biotech AG. (1/21/19). "Press Release: Partnership in China and EIB Financing [Not for US, AU, CA, JP or any other jurisdiction where prohibited by applicable law]". Vienna.

Organisations Organisation Marinomed Biotech AG (VSE: MARI)
  Organisation 2 Link Health (Guangzhou LingSheng Pharma Tech Co., Ltd.)
Products Product Marinosolv® technology platform
  Product 2 business development (state/region)
Index terms Index term Link Health–Marinomed: drug delivery technology, 201901– collab registration + distribution of Marinosolv products in China by Link Health
  Index term 2 Marinomed–EU (govt): credit, 20901–2027 up to €15m EIB credit 2019–2022 repayable 2024–2027
Persons Person Grassauer, Andreas (Marinomed Biotechnologie GmbH 201307 CEO)
  Person 2 Prieschl-Grassauer, Eva (Marinomed Biotechnologie GmbH 201307 CSO)
     


   
Record changed: 2019-02-03

Advertisement

Picture EBD Group BIO-Europe Spring 2019 BES Wien Partnering Opens 600x60px

More documents for Marinomed Biotech AG (VSE: MARI)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture BIO Deutschland Biotech Investors Day BID 2019 Würzburg 600x60px




» top